Sponsor and CRO Share Perspective on Mitigating COVID-19 Risks in a Complex Pain Program in Free Webinar

 

Sponsor and CRO Share Perspective on Mitigating COVID-19 Risks in a Complex Pain Program in Free Webinar

 

WHAT:            UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks, scheduled during the height of the COVID-19 pandemic.

UNITY and Rho are offering a free webinar, “Mitigating COVID-19 Risks in a Complex Pain Program – a Sponsor and CRO Perspective”, on Wednesday, May 19, from 1-2 p.m. EST, to highlight the creative solutions they implemented to keep the trial on track, as well as how they worked together to pivot quickly and meet critical study timelines amid the pandemic.

Topics in this webinar will include:

ü  Challenges this team overcame during program execution

ü  Real-world solutions to keep your program on-track during COVID-19

ü  Insights for productive collaboration between Sponsors and CROs

 

WHO:                    Akbar Khan, VP of Clinical Operations, UNITY Biotechnology

                                Nicholas Poulson, Senior Project Manager, Rho

                                Fran Sawyer, Clinical Team Lead, Rho

 

WHEN:                 Wednesday, May 19, 2021, 1-2 p.m. EST

 

WHERE:               Register to attend this free webinar at this link.

 

DETAILS:           For media inquiries, please contact Kelly Maicon at Largemouth Communications,                                                       919-459-6450, kmaicon@largemouthpr.com.  

 

ABOUT:           Rho, a privately-held, contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For over 35 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Facebook, LinkedIn and Twitter.